MoneyWorks4Me

Shree Ganesh Biotech (India) informs about outcome of board meeting

25 Jul 2022 Evaluate
Shree Ganesh Biotech (India) has informed that the Company has considered and approved Un-audited financial results for the quarter ended as on 30th June, 2022; Consider and accepted the Resignation of Varun Aghara from the Post of Chief Financial Officer of the Company with effective from 25.07.2022; Kishan Nityanand Naidu is appointed as Chief Financial Officer of the Company with effective from 25.07.2022; Manisha Patel has resigned from the post of directorship of the Company with effective from 25.07.2022; Nimesh Parmar is appointed as Director of the Company with effective from 25.07.2022; Amruta Solanki is appointed as Director of the Company with effective from 25.07.2022. 

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh BioTech Share Price

0.51 -0.01 (-1.92%)
17-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys (India) 1529.25
Mangalam Global Ent. 14.64
Kaveri Seed 772.20
Regaal Resources 90.11
Simran Farms 152.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: